Adams Street Partners LLC holds a concentrated book of 3 stocks worth $260.3M as of Q1 2026 (disclosed May 15, 2026, a ~45-day 13F lag). Their largest long position is BillionToOne, Inc. at 52% of the equity book.
The public view is the crawlable proof. The same sourced dataset is available through REST and MCP for agents, research scripts, and back-office tools.
This fund page is the Follow view. The Build view lets your agent pull holdings, quarter changes, overlap, and source filings through API or MCP.
curl -H "Authorization: Bearer YOUR_API_KEY" \ "https://arkolith.com/api/v1/funds/1193586/holdings"
Use Arkolith to show ADAMS STREET PARTNERS LLC's latest holdings, largest changes, and filing provenance.
Top-heavy: concentrated book
Share of the disclosed book in its largest positions. A higher top-5 share means a more concentrated, higher-conviction portfolio.
0% mapped to company sectors
Direct operating-company sectors from our SIC-based security master. ETF/fund and unclassified holdings stay visible separately; this is not ETF look-through exposure.
Estimated $ traded · quarter-end prices, no cost basis
No buys this quarter.
Other tracked managers holding the same core names as Adams Street Partners LLC
| Manager / fund | Shared names | Their $ in those |
|---|---|---|
| FMR LLC | 5 / 3 | $562.9M |
| BlackRock, Inc. | 5 / 3 | $221.6M |
| VANGUARD GROUP INC | 5 / 3 | $215.8M |
| VANGUARD CAPITAL MANAGEMENT LLC | 5 / 3 | $191.8M |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 5 / 3 | $147.8M |
| STATE STREET CORP | 5 / 3 | $84.4M |
| JPMORGAN CHASE & CO | 5 / 3 | $82.1M |
| UBS Group AG | 5 / 3 | $71.5M |
Ranked by how many of Adams Street Partners LLC's top 3 disclosed names each fund also holds: a cross-fund conviction signal from the latest 13F of every tracked manager.
Bars show each stock's share of the portfolio. Click a row for its position history.
| # | Security | Value | Shares | % Port | Last move | History |
|---|---|---|---|---|---|---|
| 1 | BillionToOne, Inc. Class A | $135.1M | 1.71M | 51.9% | —Held | |
| 2 | Rimini Street, Inc. Common | $77.3M | 23.57M | 29.7% | —Held | |
| 3 | Corvus Pharmaceuticals, Inc. Common | $47.9M | 3.28M | 18.4% | —Held |
As-of date vs the date the SEC received each filing
| Quarter | As of | Filed | Positions | Value | Form |
|---|---|---|---|---|---|
| Q1 2026 | Mar 31, 2026 | May 15, 2026 | 3 | $260.3M | 13F-HR |
| Q4 2025 | Dec 31, 2025 | Feb 13, 2026 | 5 | $263.9M | 13F-HR |
| Q3 2025 | Sep 30, 2025 | Nov 14, 2025 | 5 | $153.2M | 13F-HR |
| Q2 2025 | Jun 30, 2025 | Aug 13, 2025 | 6 | $142.0M | 13F-HR |
| Q1 2025 | Mar 31, 2025 | May 14, 2025 | 7 | $113.0M | 13F-HR |
| Q4 2024 | Dec 31, 2024 | Feb 14, 2025 | 6 | $112.8M | 13F-HR |
| Q3 2024 | Sep 30, 2024 | Nov 14, 2024 | 6 | $181.7M | 13F-HR |
| Q2 2024 | Jun 30, 2024 | Aug 14, 2024 | 9 | $242.7M | 13F-HR |
| Q1 2024 | Mar 31, 2024 | May 14, 2024 | 12 | $251.7M | 13F-HR |
| Q4 2023 | Dec 31, 2023 | Feb 14, 2024 | 14 | $324.6M | 13F-HR |
| Q3 2023 | Sep 30, 2023 | Nov 14, 2023 | 14 | $286.2M | 13F-HR |
| Q2 2023 | Jun 30, 2023 | Aug 14, 2023 | 18 | $382.4M | 13F-HR |
| Q1 2023 | Mar 31, 2023 | May 15, 2023 | 13 | $320.6M | 13F-HR |
| Q4 2022 | Dec 31, 2022 | Feb 15, 2023 | 16 | $299.8M | 13F-HR |
| Q3 2022 | Sep 30, 2022 | Nov 14, 2022 | 13 | $365.1M | 13F-HR |
| Q2 2022 | Jun 30, 2022 | Aug 17, 2022 | 15 | $384.1M | 13F-HR |
| Q1 2022 | Mar 31, 2022 | May 16, 2022 | 17 | $540.4M | 13F-HR |
| Q4 2021 | Dec 31, 2021 | Feb 14, 2022 | 26 | $655.3M | 13F-HR |
| Q3 2021 | Sep 30, 2021 | Nov 15, 2021 | 26 | $779.2M | 13F-HR |
| Q2 2021 | Jun 30, 2021 | Aug 13, 2021 | 18 | $481.5M | 13F-HR |
| Q1 2021 | Mar 31, 2021 | May 10, 2021 | 23 | $624.1M | 13F-HR |
| Q4 2020 | Dec 31, 2020 | Feb 11, 2021 | 15 | $480.9M | 13F-HR |
| Q3 2020 | Sep 30, 2020 | Nov 13, 2020 | 14 | $379.4M | 13F-HR |
| Q2 2020 | Jun 30, 2020 | Aug 13, 2020 | 11 | $483.6M | 13F-HR |
Holdings from SEC EDGAR 13F-HR filings, updated quarterly ~45 days after quarter-end. Public domain. The book and weighting are long equity only; disclosed put/call options are listed separately and excluded from those totals. The performance line is a simulation of the disclosed long book, not an audited return.